
Josh Berlin
@BioPharmaJosh
Followers
13K
Following
4K
Media
674
Statuses
20K
I help biopharma leaders & investors build cross-border relationships in the U.S., Europe, and Asia. Retweets are not endorsements.
Washington, D.C.
Joined March 2009
Advanced Rate Discount ends Aug. 15 for Grand Rounds-Europe (Cambridge, UK, Sept. 17-19). This BioCentury conference focused on key bottlenecks in translation and how to make early-stage R&D investible. Register: Hope to see you there!
2
0
0
RT @BioCentury: Biotech IPOs, FDA-Stealth & patent threat — on the latest #BioCenturyThisWeek podcast with @SteveUsdin1 @BioPharmaJosh @Bio….
biocentury.com
There’s been a rare IPO filing on NASDAQ as LB Pharmaceuticals Inc. looks to test the market during a year that has seen little activity among U.S. ...
0
2
0
RT @BioCentury: Asia deals: Globalization is open for business. An analysis of 198 Asia deals in the last 2.5 years finds Western biotechs….
0
1
0
RT @BioCentury: A new way of thinking about academia-industry collaboration — a special #BioCenturyGrandRounds edition of the #BioCenturyTh….
0
3
0
Debate key bottlenecks in translation. Join us June 4-6 in Chicago (after #ASCO25) for 2nd BioCentury Grand Rounds R&D Conference. We will also host a European edition, Sept. 17-19, Cambridge, U.K. Hope to see you there! #BioCenturyGrandRounds .
1
1
2
Looking for investors? No #biotech event attracts more VCs than #BioEquityEurope. Join us May 12-14 in Bruges, Belgium, to celebrate the 25th edition of this destination event for CEOs and investors.
0
1
2
Early Bird for BioCentury's 4th East-West Biopharma Summit ends Dec. 31. Join us in Singapore, March 2025, for a #biotech CEO & Investor conference focused on the emerging Arc of Innovation across Asia. ✅Register: . #BioCenturyEastWest
0
1
2
Are you attending London Life Sciences Week?. If so, join @BioCentury and @BIA_UK Nov. 19 (5pm-9pm) for our 2nd CEO and Investor Dialogue and networking reception. Includes fireside chat w/ @EricTokat of Centerview. Hope to see you there! #LLSW2024
0
1
2
It was great joining the BioCentury This Week podcast to talk shop with @jeff_cranmer about our 11th China Healthcare Summit + Cincinnati chili, Kentucky bourbon & Bengals/Ravens - How about that list?. Give a listen on your morning run or walk!
podcasts.apple.com
Podcast Episode · BioCentury This Week · 10/08/2024 · 40m
0
1
1
RT @BioCentury: Beating the bear: 4Q24 Public Markets Preview on a new #BioCenturyThisWeek podcast. Plus: Introducing this year’s China Sum….
0
2
0
RT @jeff_cranmer: Incubated by Samsara, led by ex $GILD liver disease top cat Mani Subramanian, OrsoBio now has $164M+ after a series B co-….
biocentury.com
With $97 million in funding to date, OrsoBio is sufficiently capitalized to reach key clinical milestones for each of three programs with novel mechan...
0
2
0
RT @BioCentury: Eyes on the Target: In this year's Back to School essays, BioCentury asks whether the era of human first, causal biology an….
0
2
0
RT @steveusdin1: House to vote on #Biosecure Act soon after it returns on 9/9, but its fate will be determined in the Senate in the lame d….
biocentury.com
The Biosecure Act, a temporary extension of the pediatric priority review voucher program, and hearings about the IRA’s Medicare drug pricing progra...
0
2
0
RT @BioCentury: Biotech IPO buzz, pharma deal trends, Washington update — a BioCentury podcast
0
1
0
RT @BioCentury: Spots are now SOLD OUT for the #BioCenturyGrandRounds poster session, with 40+ early stage biotechs and academic innovators….
0
1
0
RT @BioCentury: Grand Rounds preview: Eyes on the target. BioCentury’s inaugural R&D meeting aims to help innovators, investors create a ne….
0
1
0
RT @BioCentury: Industry KOLs at #BioCenturyGrandRounds will discuss new targets, biomarkers, and advanced tools like EEG & fMRI for treati….
0
2
0
RT @jeff_cranmer: In an exclusive conversation with @BioCentury, Jim Wilson describes how he plans to use newly launched GemmaBio as a vehi….
biocentury.com
Jim Wilson and members of his team from the University of Pennsylvania are moving to industry to take on the challenges of gene therapy development at a t...
0
5
0